Fresenius SE & Co. (OTCMKTS:FSNUY) Sees Strong Trading Volume – Here’s Why

Fresenius SE & Co. (OTCMKTS:FSNUY) shares saw an uptick in trading volume on Tuesday . 139,025 shares were traded during mid-day trading, an increase of 189% from the previous session’s volume of 48,048 shares.The stock last traded at $14.1750 and had previously closed at $13.98.

Analyst Ratings Changes

A number of equities analysts have recently commented on the company. Morgan Stanley reissued an “overweight” rating on shares of Fresenius SE & Co. in a research report on Monday, December 15th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Fresenius SE & Co. in a report on Monday, October 27th. Two research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock has an average rating of “Buy”.

Fresenius SE & Co. Trading Up 1.3%

The company has a debt-to-equity ratio of 0.49, a current ratio of 1.26 and a quick ratio of 0.99. The business has a fifty day moving average price of $14.48 and a 200 day moving average price of $13.81.

Fresenius SE & Co. (OTCMKTS:FSNUY) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $0.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.21 by $0.02. The firm had revenue of $6.29 billion during the quarter, compared to the consensus estimate of $6.38 billion. Fresenius SE & Co. had a return on equity of 9.72% and a net margin of 5.26%. On average, research analysts expect that Fresenius SE & Co. will post 0.79 earnings per share for the current year.

About Fresenius SE & Co.

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.